A detailed history of Bridgeway Capital Management, LLC transactions in Cerus Corp stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 235,000 shares of CERS stock, worth $380,700. This represents 0.01% of its overall portfolio holdings.

Number of Shares
235,000
Previous 160,000 46.88%
Holding current value
$380,700
Previous $225,000 65.78%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$1.16 - $1.6 $87,000 - $120,000
75,000 Added 46.88%
235,000 $373,000
Q2 2025

Aug 14, 2025

BUY
$1.22 - $1.51 $195,200 - $241,600
160,000 New
160,000 $225,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $287M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.